Smith & Nephew PLC (SN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Smith & Nephew PLC (SN) has a cash flow conversion efficiency ratio of 0.172x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX912.39 Million ≈ $111.01K USD) by net assets (GBX5.29 Billion ≈ $643.75K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Smith & Nephew PLC - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Smith & Nephew PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Smith & Nephew PLC for a breakdown of total debt and financial obligations.
Smith & Nephew PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Smith & Nephew PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Roto Pumps Limited
NSE:ROTO
|
0.029x |
|
Forrester Research Inc
NASDAQ:FORR
|
0.008x |
|
Treace Medical Concepts Inc
NASDAQ:TMCI
|
-0.102x |
|
Averlogic Technologies
TWO:6198
|
-0.024x |
|
Diamond Building Products Public Company Limited
BK:DRT
|
0.054x |
|
Quantum Foods Holdings
JSE:QFH
|
0.032x |
|
BEC World Public Company Limited
BK:BEC
|
0.049x |
|
King Polytechnic Engineering Co Ltd
TWO:6122
|
-0.177x |
Annual Cash Flow Conversion Efficiency for Smith & Nephew PLC (1991–2025)
The table below shows the annual cash flow conversion efficiency of Smith & Nephew PLC from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see Smith & Nephew PLC stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX5.29 Billion ≈ $643.75K |
GBX1.31 Billion ≈ $159.63K |
0.248x | +32.27% |
| 2024-12-31 | GBX5.26 Billion ≈ $640.60K |
GBX987.00 Million ≈ $120.09K |
0.187x | +60.86% |
| 2023-12-31 | GBX5.22 Billion ≈ $634.76K |
GBX608.00 Million ≈ $73.98K |
0.117x | +30.96% |
| 2022-12-31 | GBX5.26 Billion ≈ $639.87K |
GBX468.00 Million ≈ $56.94K |
0.089x | -43.50% |
| 2021-12-31 | GBX5.57 Billion ≈ $677.46K |
GBX877.00 Million ≈ $106.71K |
0.158x | -11.07% |
| 2020-12-31 | GBX5.28 Billion ≈ $642.30K |
GBX935.00 Million ≈ $113.76K |
0.177x | -22.04% |
| 2019-12-31 | GBX5.14 Billion ≈ $625.51K |
GBX1.17 Billion ≈ $142.11K |
0.227x | +18.94% |
| 2018-12-31 | GBX4.87 Billion ≈ $593.02K |
GBX931.00 Million ≈ $113.28K |
0.191x | -18.62% |
| 2017-12-31 | GBX4.64 Billion ≈ $565.04K |
GBX1.09 Billion ≈ $132.62K |
0.235x | +9.42% |
| 2016-12-31 | GBX3.96 Billion ≈ $481.57K |
GBX849.00 Million ≈ $103.30K |
0.215x | -17.41% |
| 2015-12-31 | GBX3.97 Billion ≈ $482.55K |
GBX1.03 Billion ≈ $125.32K |
0.260x | +53.62% |
| 2014-12-31 | GBX4.04 Billion ≈ $491.55K |
GBX683.00 Million ≈ $83.10K |
0.169x | -21.09% |
| 2013-12-31 | GBX4.05 Billion ≈ $492.40K |
GBX867.00 Million ≈ $105.49K |
0.214x | -7.75% |
| 2012-12-31 | GBX3.88 Billion ≈ $472.57K |
GBX902.00 Million ≈ $109.75K |
0.232x | -12.10% |
| 2011-12-31 | GBX3.19 Billion ≈ $387.77K |
GBX842.00 Million ≈ $102.45K |
0.264x | -14.71% |
| 2010-12-31 | GBX2.77 Billion ≈ $337.39K |
GBX859.00 Million ≈ $104.52K |
0.310x | -6.12% |
| 2009-12-31 | GBX2.18 Billion ≈ $265.12K |
GBX719.00 Million ≈ $87.48K |
0.330x | -0.95% |
| 2008-12-31 | GBX1.70 Billion ≈ $206.72K |
GBX566.00 Million ≈ $68.87K |
0.333x | +42.68% |
| 2007-12-31 | GBX1.82 Billion ≈ $220.95K |
GBX424.00 Million ≈ $51.59K |
0.233x | +44.20% |
| 2006-12-31 | GBX2.17 Billion ≈ $264.51K |
GBX352.00 Million ≈ $42.83K |
0.162x | -10.64% |
| 2005-12-31 | GBX1.44 Billion ≈ $174.60K |
GBX260.00 Million ≈ $31.63K |
0.181x | -32.84% |
| 2004-12-31 | GBX1.35 Billion ≈ $163.83K |
GBX363.28 Million ≈ $44.20K |
0.270x | +11.54% |
| 2003-12-31 | GBX1.14 Billion ≈ $139.23K |
GBX276.79 Million ≈ $33.68K |
0.242x | -17.01% |
| 2002-12-31 | GBX833.21 Million ≈ $101.38K |
GBX242.85 Million ≈ $29.55K |
0.291x | +18.88% |
| 2001-12-31 | GBX589.18 Million ≈ $71.69K |
GBX144.46 Million ≈ $17.58K |
0.245x | +120.17% |
| 2000-12-31 | GBX399.84 Million ≈ $48.65K |
GBX-486.02 Million ≈ $-59.13K |
-1.216x | -1043.20% |
| 1999-12-31 | GBX892.49 Million ≈ $108.59K |
GBX115.02 Million ≈ $13.99K |
0.129x | -11.38% |
| 1998-12-31 | GBX805.88 Million ≈ $98.05K |
GBX117.19 Million ≈ $14.26K |
0.145x | -2.36% |
| 1997-12-31 | GBX762.58 Million ≈ $92.78K |
GBX113.57 Million ≈ $13.82K |
0.149x | -21.88% |
| 1996-12-31 | GBX745.62 Million ≈ $90.72K |
GBX142.14 Million ≈ $17.29K |
0.191x | +64.49% |
| 1995-12-31 | GBX625.35 Million ≈ $76.09K |
GBX72.47 Million ≈ $8.82K |
0.116x | -31.01% |
| 1994-12-31 | GBX697.12 Million ≈ $84.82K |
GBX117.10 Million ≈ $14.25K |
0.168x | +99.28% |
| 1993-12-31 | GBX514.17 Million ≈ $62.56K |
GBX43.34 Million ≈ $5.27K |
0.084x | -39.18% |
| 1992-12-31 | GBX549.35 Million ≈ $66.84K |
GBX76.14 Million ≈ $9.26K |
0.139x | -29.87% |
| 1991-12-31 | GBX538.71 Million ≈ $65.55K |
GBX106.47 Million ≈ $12.95K |
0.198x | -- |
About Smith & Nephew PLC
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more